← Back to patent-cliff list
PXS-6302
Tier C — Watch / tradePXS-6302
Syntara Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：LOXs
Indications (approved)：瘢痕, 烧伤
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of PXS-6302?
Approved indications include: 瘢痕, 烧伤.
When does the PXS-6302 patent expire?
No public expiry year is available for PXS-6302 yet; this page updates once verified.
How do I get a quote for PXS-6302 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06